编辑推荐——手术后大截肢率降低与血管内介入比较:BEST-CLI随机试验
BEST-CLI国际随机试验的亚组分析比较了慢性肢体威胁性缺血(CLTI)患者初始旁路手术与血管内治疗策略。在具备合格单段大隐静脉(SSGSV)的队列1中,手术组总截肢事件和大截肢风险低于血管内组;在不具备合格SSGSV的队列2中,两组大截肢风险无显著差异。
要点
- 队列1中手术组总截肢事件45.6% vs 血管内组54.4%(p=.001)。
- 队列1中手术组后续大截肢15.0% vs 血管内组25.6%(p=.002)。
- 队列2中手术组大截肢15.2% vs 血管内组14.1%(p=.74),无显著差异。
核心结论
- 在CLTI患者中,使用SSGSV的旁路手术在预防大截肢方面比血管内治疗更有效,主要由于小截肢后大截肢减少。
研究设计与样本
- 国际随机试验BEST-CLI的亚组分析,共纳入1 830例患者,分为两个平行队列:队列1为具备合格SSGSV的患者(n=1 434),队列2为不具备合格SSGSV的患者(n=396)。
主要发现
- 队列1平均随访2.7年,手术组总截肢事件410例(45.6%)vs 血管内组490例(54.4%)(p=.001)。
- 队列1中,约三分之一患者在指数血运重建后接受小截肢:手术组31.5% vs 血管内组34.9%(p=.17)。
- 队列1中,手术组后续大截肢需求显著少于血管内组(15.0% vs 25.6%;p=.002)。
- 队列1中,首次截肢为大截肢的患者比例手术组5.6% vs 血管内组6.0%(p=.72)。
- 队列1中,大截肢需求手术组10.3%(74/718)vs 血管内组14.9%(107/716)(p=.008);队列2平均随访1.6年,132例患者发生199次截肢事件(33.3%):手术组95次(47.7%)vs 血管内组104次(52.3%)(p=.49);大截肢需求手术组15.2%(30/197)vs 血管内组14.1%(28/199)(p=.74)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: BEST-CLI, an international randomised trial, compared an initial strategy of bypass surgery with endovascular treatment in chronic limb threatening ischaemia (CLTI). In this substudy, overall amputation rates and risk of major amputation as an initial or subsequent outcome were evaluated. METHODS: A total of 1 830 patients were randomised to receive surgical or endovascular treatment in two parallel cohorts: patients with adequate single segment great saphenous vein (SSGSV) (n = 1 434) were assigned to cohort 1; and patients without adequate SSGSV (n = 396) were assigned to cohort 2. Differences in time to first event and number of amputations were evaluated. RESULTS: In cohort 1, there were 410 (45.6%) total amputation events in the surgical group vs. 490 (54.4%) in the endovascular group (p = .001) during a mean follow up of 2.7 years. Approximately one in three patients underwent minor amputation after index revascularisation: 31.5% of the surgical group vs. 34.9% in the endovascular group (p = .17). Subsequent major amputation was required significantly less often in the surgical group compared with the endovascular group (15.0% vs. 25.6%; p = .002). The first amputation was major in 5.6% of patients in the surgical group and 6.0% in the endovascular group (p = .72). Major amputation was required in 10.3% (74/718) of patients in the surgical group and 14.9% (107/716) in the endovascular group (p = .008). In cohort 2, there were 199 amputation events in 132 patients (33.3%) during a mean follow up of 1.6 years: 95 (47.7%) in the surgical group vs. 104 (52.3%) in the endovascular group (p = .49). Major amputation was required in 15.2% (30/197) of patients in the surgical group and 14.1% (28/199) in the endovascular group (p = .74). CONCLUSION: In patients with CLTI, surgical bypass with SSGSV was more effective than endovascular treatment in preventing major amputations, mainly due to a decrease in major amputations subsequent to minor amputations.
引用
- Venermo MA, Farber A, Schanzer A, et al. Editor's Choice - Reduction of Major Amputations after Surgery versus Endovascular Intervention: The BEST-CLI Randomised Trial. Eur J Vasc Endovasc Surg. 2024. PMID: 38925339. doi:10.1016/j.ejvs.2024.06.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。